Ecole Polytechnique Federale De Lausanne, Epfl

Ecole Polytechnique Federale De Lausanne (EPFL), a Swiss non-profit research university based in Lausanne, operates as a federal grant recipient and consortia member on Other Transaction Agreements, conducting fundamental and applied research in quantum information science, photonic integrated circuits, biomedical engineering, and advanced materials for the Department of Defense, the Air Force, the Army, and the Navy. EPFL competes in full-and-open federal research funding and does not hold SBA set-aside designations.

EPFL's federal footprint centers on research grants from the Department of Defense and related agencies. The top five customer agencies account for 53% of recent awards, led by the Office of Naval Research (11 awards), the Department of the Navy (8 awards), the Army Research Development and Engineering Command (7 awards), the Department of the Air Force (7 awards), and the Defense Advanced Research Projects Agency (7 awards, $5 million combined potential value). The combined potential value across all 75 prime and sub awards reaches $5.1 million, though obligated dollars total $27.5 million — reflecting multi-year grant performance spanning back to 2002. Recent awards show activity of ten to eleven grants per year in 2023–2024, with nine in 2025 and three in 2026 year-to-date. Five awards face ultimate completion within the next twenty-four months.

EPFL holds positions on two DARPA Other Transaction IDVs: the Heterogeneous Architectures for Quantum (HARQ) effort (ceiling $2,138,306, awarded March 2026) and the Rapid Inhibitor Discovery and Development Pipeline (RIDDL Program) (ceiling $2,892,378, awarded April 2025). Recent representative prime grants include a $100,000 three-year Project Grant from the Army Research Development and Engineering Command (Basic Scientific Research, CFDA 12.431) for quantum computation verification research, awarded July 2026 with completion in June 2029; a $705,139 five-year grant from the Air Force Research Laboratory (Defense Research Sciences Program, CFDA 12.800) for ultrafast photonic circuit research, effective September 2025 through August 2030; and a $490,602 three-year Project Grant from the Defense Health Agency (Military Medical Research and Development, CFDA 12.420) for spinal cord neuroprosthesis development, effective September 2025 through August 2028. Additional recent work includes a $400,000 Cooperative Agreement from the Army Research Development and Engineering Command for silicon nitride photonic integrated circuit research (August 2025–July 2028) and a $199,966 DHA grant for neuroprosthetic management of Parkinson's disease complications (August 2025–July 2027).

As a sub-recipient, EPFL participates in multi-institutional federal research consortia. Grant sub-work includes developing implantable neurostimulators under a University of Minnesota prime (awarded January 2026); designing conformable auditory brainstem interfaces under Massachusetts Eye and Ear Infirmary (awarded August 2025); performing genomic and transcriptomic analyses for cancer research under UCSF (awarded May 2025 and October 2024); and delivering spinal cord injury repair technologies as part of a DARPA Bridging the Gap Plus consortium led by the University of California, Davis (base award December 2023, multiple task extensions). EPFL also subcontracts on contract work: delivering smart textile research and development to Arete Associates (February 2025 and August 2023) and contributing to directed compilation efforts under Purdue University (September 2024).

EPFL's capability portfolio spans quantum information science and quantum computing device design; photonic integrated circuits including lithium tantalate and silicon nitride platforms; biomedical neuroprosthetics and spinal cord stimulation; advanced materials research in metallurgy and ferroelectric phenomena; and computational research in robotics, distributed systems, and mathematical foundations for artificial intelligence. The institution leverages its Switzerland-based research infrastructure and collaborations with prominent U.S. academic partners and federal laboratories to deliver multiyear, hypothesis-driven research aligned with Department of Defense long-term technological priorities in quantum technologies, photonics, and biomedical innovation.